Other OTC Pharmaceuticals - Suriname

  • Suriname
  • In Suriname, the revenue in the Other OTC Pharmaceuticals market reached US$8.19m in 2024.
  • It is projected that this market will experience an annual growth rate of 2.26% (CAGR 2024-2029).
  • When compared to other countries worldwide, the in the United States generates the highest revenue in this market, amounting to US$7,171.00m in 2024.
  • In terms of per capita figures, each person in Suriname generates revenues of US$13.02 in 2024.
  • Suriname's Other OTC Pharmaceuticals market is witnessing a surge in demand for traditional herbal remedies.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Suriname has been experiencing steady growth in recent years, driven by customer preferences for accessible and affordable healthcare options. With an increasing emphasis on self-care and the rising demand for over-the-counter medications, Suriname has seen a surge in the consumption of Other OTC Pharmaceuticals.

Customer preferences:
Surinamese consumers have shown a growing preference for self-medication and self-care, driven by factors such as convenience, cost-effectiveness, and a desire for greater control over their health. Many individuals in Suriname rely on over-the-counter medications to treat common ailments and minor health issues. This preference for self-care has contributed to the growth of the Other OTC Pharmaceuticals market in the country.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals market in Suriname is the increasing availability and accessibility of these products. Pharmacies and drugstores are expanding their product offerings to meet the growing demand for over-the-counter medications. Additionally, online platforms and e-commerce websites have made it easier for consumers to purchase Other OTC Pharmaceuticals, further fueling market growth.Another trend in the market is the rising popularity of natural and herbal remedies. Surinamese consumers are increasingly seeking alternative healthcare options and are turning to herbal and natural products for their health needs. This trend has led to the introduction of a wide range of natural and herbal over-the-counter medications in the market.

Local special circumstances:
Suriname's healthcare system faces challenges such as limited access to healthcare facilities, especially in remote areas. As a result, many individuals rely on over-the-counter medications as a first line of treatment for their health issues. The affordability and availability of Other OTC Pharmaceuticals make them a preferred choice for many Surinamese consumers.

Underlying macroeconomic factors:
Suriname's growing economy and increasing disposable income levels have played a significant role in the development of the Other OTC Pharmaceuticals market. As individuals have more financial resources at their disposal, they are able to afford over-the-counter medications and invest in their health.In conclusion, the Other OTC Pharmaceuticals market in Suriname is experiencing growth due to customer preferences for accessible and affordable healthcare options. The increasing availability and accessibility of these products, along with the rising popularity of natural and herbal remedies, are key trends driving market growth. Suriname's limited access to healthcare facilities and the country's growing economy and disposable income levels also contribute to the development of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)